Trial
NCT05494866
A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
German Cancer Research Center
Collaborators
University Hospital Heidelberg
Condition
CYP3A Inhibitor
Intervention
Cobicistat Oral Tablet
Why stopped
lack of efficacy paired with high toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-25